Edwards Lifesciences Corporation (EW) Downgrade Issued by Wall Street Gurus – News Heater
Home  »  Hot Stocks   »  Edwards Lifesciences Corporation (EW) Downgrade Is...

Edwards Lifesciences Corporation (EW) Downgrade Issued by Wall Street Gurus

Edwards Lifesciences Corporation (NYSE:EW) went up by 3.12% from its latest closing price compared to the recent 1-year high of $131.73. The company’s stock price has collected 5.45% of gains in the last five trading sessions. Barron’s reported on 04/27/22 that Edwards Lifesciences Stock Falls on Guidance Miss. This Analyst Says to Buy the Pullback.

Is It Worth Investing in Edwards Lifesciences Corporation (NYSE :EW) Right Now?

Edwards Lifesciences Corporation (NYSE:EW) scored a price-to-earnings ratio above its average ratio, recording 38.37 x from its present earnings ratio. Plus, the 36-month beta value for EW is at 1.17. Opinions of the stock are interesting as 15 analysts out of 24 who provided ratings for Edwards Lifesciences Corporation declared the stock was a “buy,” while 2 rated the stock as “overweight,” 7 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $125.53, which is $31.91 above the current price. EW currently public float of 616.88M and currently shorts hold a 1.06% ratio of that float. Today, the average trading volume of EW was 2.86M shares.

EW’s Market Performance

EW stocks went up by 5.45% for the week, with a monthly drop of -2.61% and a quarterly performance of -12.67%, while its annual performance rate touched -10.63%. The volatility ratio for the week stands at 2.92% while the volatility levels for the past 30 days are set at 3.23% for Edwards Lifesciences Corporation. The simple moving average for the period of the last 20 days is -0.58% for EW stocks with a simple moving average of -16.45% for the last 200 days.

Analysts’ Opinion of EW

Many brokerage firms have already submitted their reports for EW stocks, with Truist repeating the rating for EW by listing it as a “Buy.” The predicted price for EW in the upcoming period, according to Truist is $145 based on the research report published on April 13th of the current year 2022.

Wolfe Research, on the other hand, stated in their research note that they expect to see EW reach a price target of $134. The rating they have provided for EW stocks is “Outperform” according to the report published on April 06th, 2022.

Bernstein gave a rating of “Outperform” to EW, setting the target price at $135 in the report published on March 16th of the current year.

EW Trading at -8.46% from the 50-Day Moving Average

After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.93% of loss for the given period.

Volatility was left at 3.23%, however, over the last 30 days, the volatility rate increased by 2.92%, as shares sank -0.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.95% lower at present.

During the last 5 trading sessions, EW rose by +5.45%, which changed the moving average for the period of 200-days by -23.26% in comparison to the 20-day moving average, which settled at $94.12. In addition, Edwards Lifesciences Corporation saw -27.73% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EW starting from Zovighian Bernard J, who sale 4,809 shares at the price of $87.75 back on Jun 14. After this action, Zovighian Bernard J now owns 26,008 shares of Edwards Lifesciences Corporation, valued at $421,990 using the latest closing price.

WANG HUIMIN, the CVP, Japan & Intercontinental of Edwards Lifesciences Corporation, sale 3,675 shares at $87.75 during a trade that took place back on Jun 14, which means that WANG HUIMIN is holding 99,337 shares at $322,481 based on the most recent closing price.

Stock Fundamentals for EW

Current profitability levels for the company are sitting at:

  • +30.78 for the present operating margin
  • +76.57 for the gross margin

The net margin for Edwards Lifesciences Corporation stands at +28.73. Equity return is now at value 27.50, with 18.80 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.08.

Is Bitfarms Ltd. (BITF) a Keeper?

Bitfarms Ltd. (NASDAQ:BITF) went down by -7.33% from its latest closing price compared to the recent 1-year high of $9.36. The company’s stock price has